Allison Marlow
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cutaneous Melanoma Detection and Management
-
- Melanoma and MAPK Pathways
- PI3K/AKT/mTOR signaling in cancer
Papers in
- Oncology 2
- Drug Transport and Resistance Mechanisms 1
- Colorectal Cancer Treatments and Studies 1
-
- Computational Drug Discovery Methods 1
- Co-authors
- Eli M. Wallace (1 shared paper)Barbara J. Brandhuber (1 shared paper)Brian Hurley (1 shared paper)Kevin M. Koch (1 shared paper)Joe Lyssikatos (1 shared paper)Tammie C. Yeh (1 shared paper)Patrice A. Lee (1 shared paper)James D. Winkler (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (1 paper)Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Allison Marlow
4 papers receiving 1.0k citations
Allison Marlow's Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 360
- Molecular Biology 703
- Pathology and Forensic Medicine 126
- Computational Theory and Mathematics 110
- Cancer Research 66
Countries citing papers authored by Allison Marlow
This map shows the geographic impact of Allison Marlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Marlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Marlow more than expected).
Fields of papers citing papers by Allison Marlow
This network shows the impact of papers produced by Allison Marlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Marlow. The network helps show where Allison Marlow may publish in the future.
Co-authors
The 25 scholars most cited alongside Allison Marlow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers Hit paper breakdown → | 2008 | 512 |
| 2 | 2007 | 490 | |
| 3 | 2013 | 56 | |
| 4 | Preclinical development of ARRY-142886, a potent and selective MEK inhibitor | 2004 | 16 |
About Allison Marlow
Allison Marlow is a scholar working on Oncology, Computational Theory and Mathematics, Physiology, Molecular Biology and Insect Science, having authored 4 papers that have together received 1.1k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (2 papers), Computational Drug Discovery Methods (1 paper), Alzheimer's disease research and treatments (1 paper), Drug Transport and Resistance Mechanisms (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (360 citations), Molecular Biology (703 citations), Pathology and Forensic Medicine (126 citations), Computational Theory and Mathematics (110 citations) and Cancer Research (66 citations). Allison Marlow has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Eli M. Wallace, Barbara J. Brandhuber, Brian Hurley, Kevin M. Koch, Joe Lyssikatos, Tammie C. Yeh, Patrice A. Lee, James D. Winkler, Vivienne Marsh and Ron J. Evans. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.